Navigation Links
AdvanDx's PNA FISH(TM) Test Shown to Reduce Mortality by 42% for Patients With Hospital-Acquired Enterococcus faecium Bloodstream Infections

rococci, including E. faecium, directly from GPCPC positive blood cultures in hours instead of days. As a result, laboratories can provide faster information that enables clinicians to select effective antibiotic therapy sooner for patients afflicted with enterococcal bloodstream infections.(1)

The study included 224 patients with hospital-acquired enterococcal bloodstream infections; 112 patients before the PNA FISH test was implemented (Pre-PNA FISH group) and 112 after implementation (PNA FISH group). A treatment algorithm based on the rapid PNA FISH results was developed and implemented by the hospital's antimicrobial management team. Patients with E. faecalis by PNA FISH were to be given ampicillin, while patients with other enterococci, including E. faecium, and at "high risk" for VRE were to be given linezoid, a newer anti-VRE antibiotic. At the end of the study, data on characteristics, therapy and outcomes between the Pre-PNA FISH and PNA FISH patients groups were compared.(1)

Significant UMMC Study Data (Pre-PNA FISH vs. PNA FISH Groups)(1)

-- More than 88% of all E. faecium were resistant to vancomycin (VRE) and

100% were resistant to ampicillin

-- 84% of initial empirical antimicrobial therapy for patients with E.

faecium BSI's was inadequate

-- 2.6 days reduction in time to laboratory identification results in PNA

FISH group

-- 1.8 days reduction in time to appropriate antimicrobial therapy for E.

faecium in PNA FISH group

-- 42% reduction in 30-day mortality rates for patients with E. faecium in

PNA FISH group

-- PNA FISH Sensitivity, Specificity, Positive Predictive Value and

Negative Predictive Value shown to be 100% compared to conventional


"Use of PNA FISH in conjunction with a treatment algorithm led to earlier identification of the Enterococcus species for patients with hospital-acquired enterococcal bloodstream i

Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. AdvanDx Receives FDA 510(k) Clearance for Yeast Traffic Light PNA FISH(TM)
2. With the BEAUTIFUL Results, Procoralan* (ivabradine) is the First Antianginal Treatment Shown to Reduce Myocardial Infarction (Heart Attack) and Revascularisation in Stable Coronary Patients
3. Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over
4. Innovative Fosshield(R) Antimicrobial Technology Shown to Continuously Kill MRSA Superbug
5. EnrichMap Announces New Program To Reduce Medical Patient Noncompliance And Offers Healthcare Organizations A Limited Trial Test Opportunity
6. Bucindolol Significantly Reduces Hospitalization and Death in Heart Failure Patients With Very Favorable Genotypes
7. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
8. Roche and Response Biomedical Corporation Aim to Reduce Vein-to-Brain Time with New Point-of-Care Cardiac Tests
9. Carbon hoofprint: Cows supplemented with rbST reduce agricultures environmental impact
10. Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children
11. Studies Show USGI Medicals EndoSurgical Operating System(TM) Enables Incisionless Surgery to Reduce Gastric Pouch and Stoma After Gastric Bypass
Post Your Comments:
(Date:10/8/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: ... the development of autologous cell therapies, today announced its schedule ... place in the month of October: Stem ... RepliCel will be presenting at the annual Partnering Forum, ... to be held October 7-9 in La ...
(Date:10/8/2015)... ... October 08, 2015 , ... Cystic fibrosis (CF) is a ... gene and results in dysfunction of the lungs and the gastrointestinal (GI) tract. ... mucus is very difficult to clear, blocks the airways and the glands, and ...
(Date:10/7/2015)... , Oct. 7, 2015  ChromaDex Corp. ... and nutritional ingredients that creates science-based solutions for ... nutrition, and pharmaceutical products, today announced that the ... CEO and Founder, is now available for on-demand ... -->   --> ...
(Date:10/7/2015)... , Oct. 7, 2015   Intrexon Corporation ... today announced it will hold an Investor Day in ... afternoon of Thursday, November 12, 2015. Intrexon,s Chairman and ... other members of the Company,s management team as well ... focus on strategic initiatives, product pipeline, and program updates ...
Breaking Biology Technology:
... VANCOUVER, March 9 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. ... announced positive clinical study results for its Bio-Seal(TM) ... of Interventional Radiologists Annual Scientific Meeting in San ... efficacy of Bio-Seal in patients undergoing lung biopsy ...
... 9 /PRNewswire-FirstCall/ - Oncothyreon Inc. (NASDAQ: ONTY ) ... year and quarter ended December 31, 2008. , Net income ... or $0.37 per basic and $0.36 per diluted share, compared ... basic and diluted share, for the year ended December 31, ...
... SANTA MONICA, Calif., March 9 Cord Blood America, ... stem cell preservation company ( ) focused ... to families nationwide and internationally, said today that it ... eliminating restrictions on Federal funding of stem cell research ...
Cached Biology Technology:
(Date:9/30/2015)... 2015  The U.S. Court of Appeals for the ... in favor of Crossmatch ™, affirming the International ... Suprema and its U.S. partner Mentalix violated Section 337 ... that declares it unlawful to engage in "unfair practices" ... Crossmatch,s patents, the 5,900,993 patent and the 7,203,344 patent. ...
(Date:9/28/2015)... Sept. 28, 2015 CLEAR, the ... its expedited traveler service is coming to ... travel, bringing a frictionless experience, serious speed ... "CLEAR offers our travelers an expedited ... said Jim Smith , Executive Director, ...
(Date:9/28/2015)... JOSE, Calif. , Sept. 28, 2015 ... of human interface solutions, today announced that Lenovo has ... touch fingerprint sensor, FS4202, for its latest smartphone, the ... secure, password-free access to unlock the device and provide ... The feature-rich Natural ID FS4202 sensor ...
Breaking Biology News(10 mins):
... 24, 2011) -- Neither births nor deaths stop the flocking ... J. Toner of the University of Oregon. The notion, he ... new cancer therapies. Picture any scenario in which self-propelled ... fish, and even tiny plastic rods on a vibrating table ...
... saved an iconic Australian lizard species from death at the ... the March issue of The American Naturalist . It,s ... for the arrival of another, says Richard Shine, a biologist ... Cane toads were introduced in Australia in the ...
... injured, the rest of the school takes off in fear, tipped ... in German). Now, researchers reporting online on February 23 in the ... that scary stuff is really made of. Within that ... in fish skin. When a fish is wounded, fragments of the ...
Cached Biology News:
Rabbit polyclonal to Factor IX ( Abpromise for all tested applications). entrezGeneID: 2158 SwissProtID: P00740...
Adhesion Molecule Antibodies...
Rabbit polyclonal to Glutathione S Transferase alpha ( Abpromise for all tested applications). Antigen: Full length protein: Human Glutathione S Transferase alpha. Entrez GeneID: 2938 Swi...
Polyclonal antiserum raised against conjugated L-isoleucine. Available as antiserum. Amino Acid Antibodies...
Biology Products: